Skip to main content
Premium Trial:

Request an Annual Quote

Michael Monko, Frank Burgaezy, Roger Durst, Bernard Kolodziej, Bruker AXS, Quark Biotech, Agilent, ABI, DuPont, MDS Sciex

People

Serologicals last week named Michael Monko as vice president of sales for its research products segment. Monko previously spent 20 years in various sales positions at Invitrogen. He most recently served as Invitrogen's senior director of sales force effectiveness. He holds an MBA from Babson College and a BS in biochemistry from the University of New Hampshire. Monko will be based in Serologicals' Temecula, Calif., office.


Bruker AXS announced this week the promotions of Frank Burgaezy, Roger Durst, and Bernard Kolodziej to executive vice presidents. Burgaezy now leads the Bruker AXS X-ray diffraction and X-ray fluorescence businesses, and has global responsibility for marketing at Bruker AXS. Durst leads the Bruker AXS X-ray single crystal diffraction business, and as chief technology officer heads global R&D. Kolodziej leads the global finance function and European operations, as well as several subsidiaries of Bruker AXS.

BioCommerce Briefs

Bruker AXS to Acquire French X-Ray Analysis Software Firm

Bruker AXS will acquire French X-ray analysis-software company Socabim for an undisclosed sum, the company said this week.

Socabim has already been providing software for X-ray diffraction and X-ray fluorescence materials analysis to Bruker AXS. Bruker plans to merge Socabim with its own French subsidiary near Paris.

Socabim employees are expected to remain with the company following the acquisition, which is expected to close in the first quarter of 2006.

"We believe that with the addition of the Socabim technology and R&D team, our products can accelerate their 'time-to-market,' and our X-ray systems for advanced research and process analysis [...] will be even more powerful and user-friendly," said Frank Burgazy, managing director of Bruker AXS and president of the French subsidiary, in a company statement.


Quark Biotech Becomes Certified CGH Service Shop for Agilent Arrays

Quark Biotech has become a certified service provider for Agilent Technologies' microarrays used for array comparative genomic hybridization services, the company said this week.

Quark has been a certified service provider for Agilent's gene expression microarrays since April.

The certification includes sample receipt, labeling, and the use of Agilent's CGH platform for hybridization and data analysis, Quark said in a statement.


ABI, DuPont to Co-Develop Pathogen Detection Tools for Food Industry

Applied Biosystems and DuPont Qualicon will co-develop new pathogen-detection applications for the food industry, the companies said this week.

The new products will be based on DuPont's Bax system, which uses PCR to detect microorganisms in food. ABI's TaqMan real-time PCR technology will add additional capabilities to the system, such as quantitation, strain discrimination, and detection of new organisms.

DuPont Qualicon is a DuPont business based in Wilmington, Del.


MDS Sciex to Move Beyond Mass Spec with Cell Analysis Platform

MDS Sciex is diversifying its product offerings beyond its flagship line of mass spectrometry instruments to include cellular analysis, the company said at IBC's Drug Discovery Technology conference, held in Boston last week.

MDS Sciex, the analytical instruments division of publicly traded biotech firm MDS, was previewing its newest product, CellKey, at the meeting. A company official told BioCommerce Week's sister publication Cell-Based Assay News that it plans to officially launch the product next month at the Society for Biomolecular Screening conference in Geneva.

CellKey is a label-free cellular analysis platform based on cellular dielectric spectroscopy. In this technique, cells are grown on electrodes embedded in microwell plates, and a constant low-level voltage is applied. A detection instrument senses changes in electrical impedance that result from changes in cell morphology, confluence, adherence, and interactions.


Note to Subscribers:
BioCommerce Week
will not publish on Aug. 25 or Sept. 1. The next issue of the newsletter will appear on Sept. 8.
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.